Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Weinig risico op CTEPH na COVID-19-opname
jan 2025 | Pulmonale hypertensie, Virale infecties